OrbusNeich Medical Group Holdings Limited announced that Mr. Ching Chung John CHOW, an Executive Director, has retired from the Group of all executive roles and has been re-designated as a Non-executive Director with effect from September 7, 2023. Mr. Chow, aged 65, has been a Director since July 22, 2021 and was re-designated as an Executive Director on September 29, 2021. Mr. Chow was the head of business development of the Group, primarily responsible for overseeing overall business development activities of the Group prior to his retirement.

Mr. Chow has around 38 years of experience in interventional cardiology. He worked in Cordis-Neich Limited in May 1984 and was promoted as the general manager in January 1991. Prior to joining the Group, he was appointed as the Asia Pacific regional marketing director of the Cordis franchise in Johnson & Johnson in June 1999.

After his employment at Johnson & Johnson, Mr. Chow joined the Group in August 2000 and served as the head of sales and marketing for the Asia Pacific region from 2010 to 2015. Mr. Chow was appointed as the director of business development of the Group on May 17, 2006 and was appointed as the head of business development on September 29, 2021. Mr. Chow obtained his Bachelor of Arts degree from York University in Canada in June 1980.